CV TAG discussion papers regarding adverse effects of using a "leaky" COVID vaccine
Simon Brown made this Official Information request to Ministry of Health
Ministry of Health did not have the information requested.
From: Simon Brown
Dear Ministry of Health,
I would like to learn what discussions were had by the COVID Vaccine Technical Advisory Group regarding the potential long term detrimental safety implications of using a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 vaccine. I am specifically interested in any and all discussions regarding the use of a "leaky" vaccine as described in Pfizers original application for FDA Emergency use Authorization, subsequently confirmed by numerous international studies, including the most recent Israeli study by Gazit et al (https://www.medrxiv.org/content/10.1101/...)
I specifically would like the minutes of meetings and any formal papers/submissions by CV-TAG members that address the following issues with the vaccinated and why they are not considered either a short and/or long term public health risk:
1. increased risk of escape variants
2. disease reservoirs and increased risk for reverse zoonosis
3. high viral loads and viraemia
4. increased risk of coagulopathies
5. increased risk of autoimmunities, antibody-dependent enhancement (ADE) and acute lung injury (ALI).
Yours faithfully, Simon
From: OIA Requests
Kia ora Simon,
Thank you for your request for official information received on 4
September 2021 for:
"I would like to learn what discussions were had by the COVID Vaccine
Technical Advisory Group regarding the potential long term detrimental
safety implications of using a two-dose regimen of the BioNTech/Pfizer
mRNA BNT162b2 vaccine. I am specifically interested in any and all
discussions regarding the use of a "leaky" vaccine as described in Pfizers
original application for FDA Emergency use Authorization, subsequently
confirmed by numerous international studies, including the most recent
Israeli study by Gazit et al
([1]https://scanmail.trustwave.com/?c=15517&...)
I specifically would like the minutes of meetings and any formal
papers/submissions by CV-TAG members that address the following issues
with the vaccinated and why they are not considered either a short and/or
long term public health risk:
1. increased risk of escape variants
2. disease reservoirs and increased risk for reverse zoonosis 3. high
viral loads and viraemia 4. increased risk of coagulopathies 5. increased
risk of autoimmunities, antibody-dependent enhancement (ADE) and acute
lung injury (ALI).”
The Ministry's reference number for your request is: H202111756.
As required under the Official Information Act 1982, the Ministry will
endeavour to respond to your request no later than 1 October 2021, being
20 working days after the day your request was received.
Due to the COVID-19 global pandemic response, the Ministry is experiencing
significantly higher volumes of queries and requests for information. If
we are unable to respond to your request within this time frame, we will
notify you of an extension of that time frame.
If you have any queries related to this request, please do not hesitate to
get in touch.
Ngâ mihi
OIA Services
Government Services
Office of the Director-General
Ministry of Health
E: [2][email address]
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. https://scanmail.trustwave.com/?c=15517&...
2. mailto:[email address]
hide quoted sections
From: OIA Requests
Kia ora Simon,
Thank you for your request for official information, received on 4
September 2021 requesting:
“I would like to learn what discussions were had by the COVID Vaccine
Technical Advisory Group regarding the potential long term detrimental
safety implications of using a two-dose regimen of the BioNTech/Pfizer
mRNA BNT162b2 vaccine. I am specifically interested in any and all
discussions regarding the use of a "leaky" vaccine as described in
Pfizers original application for FDA Emergency use Authorization,
subsequently confirmed by numerous international studies, including the
most recent Israeli study by Gazit et al
(https://scanmail.trustwave.com/?c=15517&...)
I specifically would like the minutes of meetings and any formal
papers/submissions by CV-TAG members that address the following issues
with the vaccinated and why they are not considered either a short
and/or long term public health risk:
1. increased risk of escape variants
2. disease reservoirs and increased risk for reverse zoonosis 3. high
viral loads and viraemia 4. increased risk of coagulopathies 5.
increased risk of autoimmunities, antibody-dependent enhancement (ADE)
and acute lung injury (ALI).”
The Ministry of Health has decided to extend the period of time available
to respond to your request under section 15A of the Official Information
Act 1982 (the Act) as further collation is required.
You can now expect a response to your request on, or before, 14 October
2021.
You have the right, under section 28 of the Act, to ask the Ombudsman to
review my decision to extend the time available to respond to your
request.
Ngâ mihi
OIA Services Team
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
hide quoted sections
From: OIA Requests
Kia ora Simon,
Please find attached a response regarding your request for
information.
Ngā mihi
OIA Services Team
[1]Ministry of Health information releases
[2]Unite against COVID-19
****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************
--------------------------------------------------------------------------
This e-mail message has been scanned for Viruses and Content and cleared
by the Ministry of Health's Content and Virus Filtering Gateway
--------------------------------------------------------------------------
References
Visible links
1. https://www.health.govt.nz/about-ministr...
2. https://covid19.govt.nz/
hide quoted sections
From: Simon Brown
Dear OIA Requests,
Thank you for your response which I find both revealing and vexatious. Surely the role of a Technical Advisory Group is to front-run and control for potential problems, especially when dealing with novel therapeutics that could seriously undermine a recipients immune system with significant long-term consequences for wider public health. After all this is not an unknown unknown risk but a set of known unknowns as anyone with a cursory interest in the history of corona and "leaky" vaccines can attest to. Not only does it appear Medsafe rubber stamped emergency approval of the BNT162b2 vaccine but it's advisors failed to entertain, let alone discuss, potential negative consequences. I do hope our blind rush to mass vaccinate against a virus in the middle of a global pandemic (which molecular epidemiologists now confirm is evolving to escape vaccinal control as predicted) does not come back to harm the population in the long run as this virus inevitably becomes endemic.
Yours sincerely,
Simon Brown (PhD)
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this requestAct on what you've learnt
Similar requests
Astra Zeneca
To Chris Hipkins by M.R.M.
Informed Consent #25 - Miscarriage and stillbirth rates in rat study
To Andrew Little by Annie Weston
